Fig. 1From: Prognostic impact of 18F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancerDisease-free survival according to metabolic parametersBack to article page